You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


UCB announces approval of Bimzelx

UCB has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for Bimzelx, also known as bimekizumab.